TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmacosweden AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
17,295
|
16,521
|
15,225 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
820
|
788
|
698 |
EBITDA |
1,525
|
1,353
|
1,131 |
Total assets |
8,626
|
8,153
|
7,379 |
Current assets |
5,398
|
6,570
|
6,202 |
Current liabilities |
3,240
|
3,243
|
2,983 |
Equity capital |
5,386
|
4,910
|
4,396 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
9
![]() |
9
![]() |
9 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
62.4%
|
60.2%
|
59.6% |
Turnover per employee |
1,922
|
1,836
|
1,692 |
Profit as a percentage of turnover |
4.7%
|
4.8%
|
4.6% |
Return on assets (ROA) |
9.5%
|
9.7%
|
9.5% |
Current ratio |
166.6%
|
202.6%
|
207.9% |
Return on equity (ROE) |
15.2%
|
16.0%
|
15.9% |
Change turnover |
774
|
1,296
|
4,509 |
Change turnover % |
5%
|
9%
|
42% |
Chg. No. of employees |
0
![]() |
0
|
2 |
Chg. No. of employees % |
0%
![]() |
0%
|
29% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.